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Bovine Respiratory Syncytial
Virus Infection
Paul Prieksat DVM*
J.R. Thompson, DVM * *
Bovine Respiratory Syncytial virus (BRSV) has
quickly become one of the major respiratory viruses
in cattle in the U. S. Literary repons from various
areas of the U.S. and Canada show that BRSV is
present in 38 to 81 percent of the beef and dairy
cattle tested. 1,3
Bovine Respiratory Syncytial virus, first isolated
in Switzerland in 1970 from an outbreak of respira-
tory disease involving dairy cattle, is a nonhemag-
glutinating pneumovirus in the family
Paramyxoviridae.2,3,1l The virus was named for its
characteristic property of promoting fusion of cells
into multinucleated giant cells (syncytial cells).
Pathogenesis
The mechanism by which BRSV causes disease
is not clearly understood. A common association of
secondary bacterial pneumonia in outbreaks of
BRSV indicates that this virus has a catastrophic
effect on the respiratory tract defense mechanisms.
Scanning electron photomicrographs made after
experimental infections have demonstrated destruc-
tion of ciliated respiratory epithelium.4 By caus-
ing extensive damage to the mucous membranes,
the virus leaves the respiratory tract susceptible to
dust, debris, and secondary infectious agents such
as bacteria and other viruses.
The pulmonary edema-emphysema and pneu-
monia caused by BRSV is, in theory, due to a hyper-
sensitivity reaction.4 ,16 This theory is based on the
observation that two separate clinical disease syn-
dromes are observed. 2 The initial stage is charac-
terized by mild respiratory signs, except when
complicated by secondary bacterial pneumonia. The
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second stage, which may follow improvement or
recovery from the initial stage, is characterized by
severe respiratory distress. Because of this biphasic
respiratory disease syndrome, it is thought that the
initial exposure may sensitize the animal, with sub-
sequent exposure inducing an anaphylactic or
hypersensitivity reaction. 16
Disease Incidence
The virus affects both dairy and beef cattle, rang-
ing in age from ten days to maturity.17 Age,
management, and environment seem to affect the
animals' susceptibility.
In beef calves, the infection is most severe dur-
ing the fall, when they are 5 to 10 months of age. 2
Such outbreaks coincide with weaning, feedlot ship-
ping, dietary changes, and other stressors that sup-
press the immune system. An association has also
been reponed between more severe outbreaks and
well managed calves on good rations. 2
The virus is most likely transmitted to suscepti-
ble calves by aerosol, direct contact, and droplet
contact from subclinically or clinically infected
calves. 2 The spread of the disease is especially ef-
ficient in closely confined herds. The virus is very
labile outside the body and is therefore unlikely to
persist in the environment. Cattle are probably the
reservoir for the virus.6 Experiments with BRSV in-
fected dams have shown that calves are not protect-
ed by colostral or passively derived antibodies. 15 This
is imponant to BRSV susceptibility of very young
calves.
The severity of disease varies considerably from
group to group, and within groups of cattle.
However, almost all calves within a group will be
affected, even though fever may be the only
abnormality. 6 Death rate also varies greatly, 0 to
25 percent, with the highest monality occurring in
well-bred animals on a high plane of nutrition. 2,6
Cenain feeds like corn silage have been associated
with an increased incidence or severity of disease.
Clinical Signs
The incubation period for the disease is three to
five days and cattle show few clinical signs before
this time. 10 Early clinical signs of disease include
mild nasal, oral, and ocular discharge, increased
respiratory rate, decreased feed and water intake,
and an increased frequency and severity of cough-
ing. Many of the calves, even those that appear nor-
mal, will have elevated temperatures ranging from
104 to 108 F.2,4 Affected calves may stand alone
with their heads down, although they brighten up
remarkably well when an observer walks among
them. 1 Consequently, to the inexperienced observ-
er, the first clinical sign may be death.
Early signs may be followed by acute disease
within hours. 6 At this time extreme respiratory dis-
tress is seen, including pronounced dyspnea, mouth
breathing, a dry hacking cough, and frothing of
saliva from the mouth. Subcutaneous edema may
be evident, especially around the eyes, throat and
neck. The animal may be seen with tongue hang-
ing out and neck extended. The calves do not eat
or drink, they lose fill, and become dehydrated.
Diarrhea has been reported but tends to be tran-
sient' since decreased feed and water intake leads
to constipation. 16 Duration of the disease ranges
from one to two weeks.
Auscultation of the lungs reveals increased bron-
chovesicular sounds with fine crackles, which are
consistent with the presence of emphysema.2 ,16
Rales and rhonchi are also commonly heard due to
the presence of secondary bacterial infections in the
lungs.
Although clinical signs and epidemiologic fea-
tures observed during outbreaks of respiratory dis-
ease may make a veterinarian suspicious of BRSV
involvement this diagnosis should be confirmed by
laboratory tests, since there are many different
agents involved in the bovine respiratory complex.
Pathological Findings
On necropsy, there is a diffuse interstitial pneu-
monia with subpleural and interstitial emphysema
and edema. 12 The lungs appear reddish pink, are
firm and have the meaty texture of adenomatosis. 1
The lungs do not collapse when the thoracic cavity
is opened, and often imprints of the ribs can be
seen on the surface of the lungs. A foamy fluid
flows from the affected portion of the lung when
cut, and there is froth in the trachea and bronchi.
If secondary bacterial pneumonia is present, areas
of the lungs may be consolidated, especially in the
cranioventral regions.
Histopathologic changes associated with BRSV
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vary with the duration of infection, and with the
presence or absence of secondary infection. 1o,u
The most severe changes are seen in small bronchi,
bronchioli and alveoli. These changes include
necrotizing and hyperplastic bronchitis and bron-
chiolitis, multifocal to locally extensive interstitial
pneumonia, and often in fatal cases, interstitial
emphysema. 5,7,10,11,12 The most characteristic
histological hallmark of BRSV infection is the for-
mation of multinucleated syncytial cells in the
epithelial cells lining the bronchi, bronchioles and
alveolar septa. 2,5,7,U,16
Diagnosis
A definitive diagnosis of BRSV cannot be con-
fumed without laboratory tests. However, it is often
difficult to obtain a positive laboratory diagnosis be-
cause the virus is difficult to isolate, and it is very
labile in transit under field conditions. As a result,
practitioners must collect proper specimens, and
process and package them properly before sending
them to a lab.
When collecting samples for testing, the obvi-
ously sick animal is not the ideal candidate because
it is usually not shedding the virus. In addition, the
animal's antibody response may neutralize the virus,
thus preventing virus isolation. 17 The best samples
are from those calves in contact with the sick
animals, or with calves that are febrile and will be
sick within four days. Calves incubating BRSV are
more likely to shed the virus. 17 The best samples
to submit for diagnostic testing include deep
nasopharyngeal swabs, transtracheal samples,
serum, and, if the calf dies or is euthanatized, fresh
lung samples from areas caudal to those of bacterial
lesions. The procedures which are currently avail-
able for diagnosing BRSV include virus isolation,
immunofluorescence testing, paired serotesting, and
histopathology which is only suggestive of BRSV
infection.
Since isolation is time consuming and lacks
sensitivity for detecting BRSV, it should be used
in conjunction with other tests. 2 The most com-
mon samples for virus isolation are nasopharyngeal
swabs, lacrimal discharge, bronchial lymph nodes,
and lung. The virus is labile and rapidly loses via-
bility during transport or if subjected to freezing
and thawing. To increase the chances for isolation,
the samples should be taken early in the course of
an infection. If isolation is going to be made on
lung tissue, the samples must be taken as soon as
possible after death. To enhance the viability of the
virus, several researchers recommend the use of a
sucrose transport medium, and storage under iced
or frozen conditions. 1
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Immunofluorescence has proven to be a highly
sensitive and specific test for the rapid diagnosis of
BRSV infection.2 Frozen lung and bronchial sec-
tions, along with nasal swabs collected from calves
early in the course of the disease, are the best sam-
ples for this test. Nasal swabs should be rolled onto
microscope slides, flXed in acetone for ten minutes,
and then sent to the lab for fluorescent antibody
testing. 17 Such testing can be performed in a few
hours, is specific, and inexpensive.
Serologic testing and comparison of paired serum
samples will allow the practitioner to evaluate a herd
for the presence of BRSV. Serologic diagnosis is
made by comparing acute and convalescent serum
antibody titers for evidence of seroconversion (four-
fold rise in antibody titer).2 When attempting a
serological diagnosis of BRSV, samples should be
submitted from ten animals or ten percent of the
herd, whichever is greater. 16 Antibody titers to
BRSV rise very rapidly within two to tllree days after
the onset of clinical signs. 1,16 Therefore, it is
important that serum samples be collected as early
as possible in a disease outbreak. Convalescent sam-
ples can be collected as early as two weeks.
A serologic diagnosis is not possible in calves with
passively derived antibody because the passive
immunity, which is not protective, suppresses the
humoral immune response. 15,16 A way around this
problem is to sample calves from various age groups
so as to include those that have lost their passive
immunity to BRSV. A newly developed ELISA test
for the detection of BRSV serum antibodies has
been shown to be a highly sensitive test. 13
Histopathology is the final method used in
diagnosing BRSV infection. The lesions have already
been discussed elsewhere in this paper. Histopathol-
ogy does not give a definitive diagnosis because
similar lesions occur in other viral and bacterial
diseases of the lung.
Treatment
Early diagnosis improves the chances of success-
ful treatment ofBRSV infected animals. All animals
in an affected herd should be given antibiotic
therapy to prevent the occurence of secondary bac-
terial pneumonia. The therapy should begin as soon
as respiratory disease is recognized, and continued
for several days after apparent recovery. Antibiotic
therapy should be initiated while bacteriologic
cultures and sensitivity tests are pending.
In some field outbreaks, the use of corticosteroids
and antihistamines have shown favorable results in
the treatment of BRSV. 16 Because of the immuno-
suppressive effect of corticosteroids, a diagnosis or
strong suspicion of BRSV is indicated before initi-
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ation of this form of therapy.
Aspirin and Banamine® (flunixin meglumine)
have been used to help reduce rectal temperatures,
and bronchiolar mucosal swelling leading to a
reduction in airway obstruction.2,9
Other recommendations in the treatment of
BRSV include withholding grain and silage from
affected animals for two to three days, and feed-
ing only enough hay to identify those animals that
are not eating.4 Calves that are severely affected
and unable to drink need to be given supportive
therapy consisting of fluids and electrolytes. 16
The following two treatment regimens have been
used extensively, and have shown considerable suc-
cess when started early.2
1.
a. Fast the affected group of calves for two
to three days; feed only enough hay to
enable identification of anorexic calves.
b. For two days, give sick calves 250mg
pyrilamine maleate twice a day and 10mg
dexamethasone once a day.
c. Start antibiotic treatment by the second
day of clinical signs; also give sustained-
release oral sulfas; in large groups of
calves, treat with antibiotics in the water.
d. On the second or third day of treatment,
give severely dehydrated calves electro-
lytes and a rumen preparation by
stomach tube.
2.
a. Change or reduce feed as necessary.
b. Treat febrile calves with aspirin (240g
bolus/300 #) once, or preferrably twice.
c. Treat parenterally with broad-spectrum
antibiotics/for 4 to 5 days; treat large
groups with sulfas in the water and
tetracyclines in the feed.
d. Give required supportive treatment as in
regimen 1.
These treatments are for calves in the late syn-
drome ofBRSV. Early syndrome calves can be treat-
ed with antibiotics only, to prevent secondary
bacterial pneumonia, but individual calves should
be watched carefully for respiratory distress, and
then treated as above when necessary.2
Prevention
Good managerial practices alone do not prevent
BRSV, but they will help prevent excessive losses.
Because it is difficult to completely control this
disease, vaccines have been developed to control
BRSV.
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BRSV vaccines have recently become available in
the U.S., and are produced by Norden Laboratories
and Diamond Scientific. These products are modi-
fied live vaccines that are given intramuscularly. A
repon of field trials using one vaccine indicated it
was safe and effective in reducing the prevalence
of repiratory disease in cattle. 8 ,14 These vaccines
are well suited for use in preconditioning programs,
or at the time of entry into feedlots. By this time,
calves have probably lost their passive immunity to
BRSV and are likely capable of mounting an active
immune response when vaccinated. 16 Dairy calves
should be vaccinated when passive immunity is lost.
Pregnant beefcows should be vaccinated at the time
of pregnancy checking, or closer to calving.
Vaccination for BRSV is not recommended
during an outbreak. During an outbreak, the wild
strain of BRSV is already in circulation, or the
infected animals have already starred to develop
antibodies to the virus. 2 In both cases, the success
of vaccination is doubtful.
Summary
BRSV is a disease thought to result from the
interaction ofBRSV virus with several other etiologic
factors which may differ from outbreak to outbreak.
When disease is produced, it is usually on a herd
basis, perhaps because calves of a highly suscept-
ible age are grouped together, with concurrent ex-
posure to other microbial agents and simultaneous
exposure to other stressors, such as cold weather or
dietary antigens, lowering herd resistance.
BRSV is often explosive in nature and is charac-
terized by pulmonary edema and emphysema. It
has a high morbidity and monality among young
calves. In addition, BRSV plays an imponant role
in predisposing calves to secondary respiratory
infections, especially bacterial pneumonia. Both
aspects of the disease have a strong economic impact
in treatment and loss.
Treatment of the acute disease is usually success-
ful if it is starred early in the course of the disease.
However, it is expensive and intensive, including
the use of antibiotics, antihistamines, and cor-
ticosteroids. In the early stages of the disease, fast-
ing or a change of feed may eliminate an outbreak.
Preventing BRSV infection requires sound
managerial practices and minimal stress. However,
the well-managed, well-nourished herds are often
hit the hardest. Vaccines for the prevention and
control of BRSV appear to be both safe and cost-
effective.
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